Bixiye
QP62-20 Medicaid Sleep Management – Home Sleep Studies
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Natiijooyinka Raadinta
Soo bandhiga 1251 - 1260 ee natiijooyinka 4162
Bixiye
QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
2020 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
QP61-20 Signify Health Virtual Visits for Medicare Advantage and SecureBlue Members
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020
Bixiye
QP58-20 Commercial Pharmacy Benefit Exclusion for Medical Drugs Anjeso™ , Fetroja™ and Potassium Phosphates
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020
Bixiye
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020